Sabnis Ram W
Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
ACS Med Chem Lett. 2024 Jul 3;15(8):1180-1181. doi: 10.1021/acsmedchemlett.4c00286. eCollection 2024 Aug 8.
Provided herein are novel imidazopyridine and imidazopyridazine derivatives as DGAT2 inhibitors, pharmaceutical compositions, use of such compounds in treating multiple diseases, and processes for preparing such compounds.
本文提供了作为DGAT2抑制剂的新型咪唑并吡啶和咪唑并哒嗪衍生物、药物组合物、此类化合物在治疗多种疾病中的用途以及制备此类化合物的方法。